Frontlight ResearchEarly access
Type 1 diabetes trials in France
23 of 43 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Bron, La Tronche, Lille, Paris, Pau
- Age
- 1 year to 25 years
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - Phase 3Not yet taking people in FranceA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Bron, Corbeil Essonnes Cedex, Lille Cedex, Marseille, Paris, Toulouse Cedex 9
- Age
- 1 year to 35 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Bouches-du-Rhône, Corbeil Essonnes Cedex, Isère, Lille Cedex, Paris, Rhône, Toulouse Cedex 9
- Age
- 1 year to 35 years
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - No phaseTaking peopleContinuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.
- Where
- Lille, Montpellier
- Age
- 18 years and over
- People
- 60
- Run by
- Solsius
See details and how to joinNCT07910721 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bobigny, Colmar Cedex, Dijon, Lyon, Paris, Pessac, Pierre-Bénite, Thionville, Toulouse Cedex 9, Vénissieux
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - Phase 2/3Not yet taking people in FranceVerapamil In Preclinical Type 1 Diabetes
- Where
- Paris
- Age
- 7 years to 45 years
- People
- 50
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07880769 · EU 2025-524318-27-00 - Phase 2Taking peopleSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Where
- Paris
- Age
- 5 years to 40 years
- People
- 159 worldwide
- Run by
- SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00 - No phaseTaking peopleEvaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Early Treatment Using an Automated Delivery System in Children With Type 1 Diabetes
- Where
- Paris
- Age
- 5 years to 8 years
- People
- 50
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06461065 - Phase 3Active, not recruitingA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Bois-Guillaume, Colmar Cedex, Le Coudray, Paris, Pessac, Pierre-Bénite, Saint-Herblain, Vénissieux
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - No phaseNot yet taking people in FranceClinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)
- Where
- Bordeaux, Corbeil-Essonnes, Dijon, Lille, Marseille, Montpellier, Nancy, Paris, Strasbourg, Toulouse
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT06739811 - Phase 2Active, not recruitingCiclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
- Where
- Paris, Paris Cedex 13
- Age
- 16 years to 45 years
- People
- 24
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05153070 · EU 2024-514043-29-00 - Phase 3Taking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Lille Cedex, Strasbourg Cedex 2
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - No phaseTaking peopleExercise Training and Endothelial Function in Type 1 Diabetes
- Where
- Lille
- Age
- 18 years to 50 years
- People
- 34
- Run by
- University Hospital, Lille
See details and how to joinNCT03528226 - No phaseTaking peopleSatisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System
- Where
- Grenoble
- Age
- 18 years and over
- People
- 900
- Run by
- University Hospital, Grenoble
See details and how to joinNCT07567170 - No phaseNot yet taking people in FranceEvaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
- Where
- Caen, Grenoble, Lyon, Nîmes, Paris
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT07401901 - No phaseTaking peopleDysautonomia in Children With Type 1 Diabetes
- Where
- Saint-Etienne
- Age
- 1 year to 17 years
- People
- 100
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT07455994 - No phaseTaking peopleCharacterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals
- Where
- Paris
- Age
- 6 years to 18 years
- People
- 80
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06427421 - No phaseTaking peopleEffects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes
- Where
- Loos
- Age
- 10 years to 16 years
- People
- 18
- Run by
- Lille University
See details and how to joinNCT06803446 - No phaseTaking peopleStudy of the Impact of PROximity Support for Patients With Type 1 DIABetes Treated With an Insulin Pump or Closed Loop.
- Where
- Nice
- Age
- 18 years and over
- People
- 340
- Run by
- timkl
See details and how to joinNCT06050642 - No phaseTaking peopleEkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation
- Where
- Bobigny, Caen, Chartres, Corbeil-Essonnes, Dijon, Le Havre, Limoges, Marseille, Mérignac, Montpellier, Paris, Périgueux, Saint-Cyr-sur-Loire, Toulouse
- Age
- 18 years and over
- People
- 154
- Run by
- DiappyMed
See details and how to joinNCT06738849 - Phase 2Not yet taking people in FranceImage-Verapamil SR in Adults with Type 1 Diabetes (Image-VER-A-T1D)
- Where
- Paris, Paris Cedex 20
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Radboud universitair medisch centrum Stichting
See details and how to joinNCT04615910 · EU 2024-518554-17-00 - No phaseTaking peopleEfficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes
- Where
- Angers, Montpellier, Paris, Tours
- Age
- 2 years to 18 years
- People
- 112
- Run by
- University Hospital, Montpellier
See details and how to joinNCT06283797 - No phaseTaking peoplePilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 8
- Run by
- Defymed
See details and how to joinNCT05221359